Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
Clinical trial NCT01310881 · COMPLETED
Trial details
- NCT number
- NCT01310881
- Sponsor
- Neuralstem Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.